What ever man, this guy and I have history. This was all discussed before and when it was I laid out FACT after FACT after FACT and all of it was supported by MDs who agreed with what I said. This guy knows this, I am simply not going to redo the entire thing. This is his pet religious belief and he lives to do this shit when ever I say anything no matter how moderate about not just shoving 8 ROUNDS of vaccines into babies before they are TWO YEARS OLD. This is insane, it absolutely is not necessary and anyone that believes it is tends to be beyond hope.

Again EIGHT rounds.

Let me add I am sure I will lay out the case again on the air and when I do, ass hat will show up yet again. The basic case is if you don’t shove 8 vaccines into a child at one time, and there is a reaction you know WHAT the reaction is to. Not to mention if there is a reaction it will likely be LESS severe if only one or two are given per round. Further that the shear number in the first two years is absolutely unreasonable.

Ass Hat here claims that any concerns about reactions are UNFOUNDED. Well the people that make the vaccines SAY THE OPPOSITE, you can read them all here, http://www.vaccinesafety.edu/package_inserts.htm

Next time someone says there are no risks to a vaccine, print a copy of the warning label of the one in question for them and ask them to read it.

People who deny such risks are religious in their trust of medicine. It is an accurate word because here you have the manufacturer say something like, this, taken word for word from Merks warning label on its own vaccine. But remember there are no risks at all right?

The following adverse reactions are listed in decreasing order of severity, without regard to causality, within each body system category and have been reported during clinical trials, with use of the marketed vaccine, or with use of monovalent or bivalent vaccine containing measles, mumps, or rubella: Body as a Whole Panniculitis; atypical measles; fever; syncope; headache; dizziness; malaise; irritability.

Cardiovascular System
Vasculitis.
Digestive System

Pancreatitis; diarrhea; vo
miting; parotitis; nausea.

Endocrine System
Diabetes mellitus.
Hemic and Lymphatic System
Thrombocytopenia (see WARNINGS,
Thrombocytopenia
); purpura; regional lymphadenopathy;
leukocytosis.

Immune System
Anaphylaxis and anaphylactoid reactions have been r
eported as well as related phenomena such as
angioneurotic edema (including peripheral or facial edem
a) and bronchial spasm in individuals with or
without an allergic history.

Musculoskeletal System
Arthritis; arthralgia; myalgia.
Arthralgia and/or arthritis (usually transient and
rarely chronic), and polyneuritis are features of
infection with wild-type rubella and vary in fr
equency and severity with age and sex, being greatest in
adult females and least in prepubertal children. This
type of involvement as well as myalgia and
paresthesia, have also been reported
following administration of MERUVAX
II

Chronic arthritis has been associated with wild
-type rubella infection and has been related to
persistent virus and/or viral antigen isolated from
body tissues. Only rarely
have vaccine recipients
developed chronic joint symptoms.
Following vaccination in children, reactions in join
ts are uncommon and generally of brief duration. In
women, incidence rates for arthritis and arthralgia are generally higher than those seen in children
(children: 0-3%; women: 12-26%),
{17,56,57} and the reactions tend to be more marked and of longer
duration. Symptoms may persist for a matter of mont
hs or on rare occasions for years. In adolescent
girls, the reactions appear to be intermediate in
incidence between those seen in children and in adult
women. Even in women older than
35 years, these reactions are gener
ally well tolerated and rarely
interfere with normal activities.

Nervous System
Encephalitis; encephalopathy; measles incl
usion body encephalitis (MIBE) (see
CONTRAINDICATIONS); subacute
sclerosing panencephalitis (SSPE); Gu
illain-Barré Syndrome (GBS);
acute disseminated encephalomyelitis (ADEM); transve
rse myelitis; febrile convulsions; afebrile
convulsions or seizures; ataxia; polyneuritis
; polyneuropathy; ocular palsies; paresthesia.
Experience from more than 80 million doses of all
live measles vaccines given in the U.S. through
1975 indicates that significant central nervous
system reactions such as encephalitis and
encephalopathy, occurring within 30 days after vacci
nation, have been temporally associated with
measles vaccine very rarely.{58} In no case has it
been shown that reactions were actually caused by
vaccine. The Centers for Disease Control and Preventi
on has pointed out that “a
certain number of cases
of encephalitis may be expected to occur in a lar
ge childhood population in a defined period of time even
when no vaccines are administered”. However, the data
suggest the possibility that some of these cases
may have been caused by measles vaccines. The risk of
such serious neurological disorders following
live measles virus vaccine administration remains
far less than that for encephalitis and encephalopathy
with wild-type measles (one per two thousand reported cases).
Post-marketing surveillance of the more
than 200 million doses of M-M-R and M-M-R
II
that have
been distributed worldwide over 25 years (1971 to 1996)
indicates that serious
adverse events such as
encephalitis and encephalopathy continue
to be rarely reported.{17}
There have been reports of subacute sclerosing panenc
ephalitis (SSPE) in children who did not have
a history of infection with wild-type measles but di
d receive measles vaccine. Some of these cases may
have resulted from unrecognized measles in the first year
of life or possibly from
the measles vaccination.
Based on estimated nationwide measles vaccine distri
bution, the association of SSPE cases to measles
vaccination is about one case per million vaccine doses di
stributed. This is far
less than the association
with infection with wild-type measles, 6-22 cases of
SSPE per million cases of measles. The results of a
retrospective case-controlled study conducted by
the Centers for Disease Control and Prevention
suggest that the overall effect of measles va
ccine has been to protect against SSPE by preventing
measles with its inherent higher risk of SSPE.{59}
Cases of aseptic meningitis have been reported to
VAERS following measles, mumps, and rubella
vaccination. Although a causal relationship betw
een the Urabe strain of mumps vaccine and aseptic
meningitis has been shown, there is no evidence
to link Jeryl Lynn™ mumps vaccine to aseptic
meningitis.

Respiratory System
Pneumonia; pneumonitis (see CO
NTRAINDICATIONS); sore throat; cough; rhinitis.

Skin
Stevens-Johnson syndrome; erythema
multiforme; urticaria; rash;
measles-like rash; pruritis.
Local reactions including burning/stinging at inje
ction site; wheal and flare; redness (erythema);
swelling; induration; tenderness;
vesiculation at injection site.
Special Senses — Ear
Nerve deafness; otitis media.
Special Senses — Eye
Retinitis; optic neuritis; papillitis;
retrobulbar neuritis; conjunctivitis.
Urogenital System
Epididymitis; orchitis.

Other
Death from various, and in some cases unknow
n, causes has been reported rarely following
vaccination with measles, mumps, and rubella va
ccines; however, a causal relationship has not been
established in healthy individuals (see CONTRAINDI
CATIONS). No deaths or permanent sequelae were
reported in a published post-marketing surveillance
study in Finland involving 1.5 million children and
adults who were vaccinated with M-M-R
II
during 1982 to 1993.{60}
Under the National Childhood Vaccine Injury Act of
1986, health-care providers and manufacturers
are required to record and report certain suspected adv
erse events occurring within specific time periods
after vaccination. However, the U.S. Department of
Health and Human Services (DHHS) has established
a Vaccine Adverse Event Reporting System (VAERS)
which will accept all reports of suspected
events.{49} A VAERS report form as well as in
formation regarding reporting requirements can be
obtained by calling VAERS 1-800-822-7967.

Don’t give me too much credit the majority was cut and paste from Merks own paperwork.